Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Determination of divalent arsenic in Chinese herbal medicines is a critical component of botanical drug quality control, protecting consumers from one of the most toxic contaminants that can accumulate in medicinal plants. This article presents the complete analytical workflow, including speciation-preserving extraction, chromatographic separation, and element-specific detection by HPLC-ICP-MS and HPLC-HG-AFS, along with sample requirements, regulatory limits, and practical application guidance.

Determination of Divalent Arsenic in Chinese Herbal Medicines

Technical Overview

Arsenic contamination in Chinese herbal medicines originates from multiple sources: geogenic arsenic in soil and groundwater, historical use of arsenical pesticides, industrial and mining emissions near cultivation sites, and cross-contamination during processing and storage. Because medicinal plants are often grown in soil-rich environments and their roots, rhizomes, and aerial parts are harvested and consumed with minimal refining, arsenic can accumulate at levels of toxicological concern.

The health risk posed by arsenic depends strongly on its chemical form rather than only its total concentration. In herbal matrices, arsenic exists principally as inorganic arsenite As(III) and arsenate As(V), with smaller proportions of methylated species such as monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA). The low-valence inorganic fraction, commonly referred to as divalent arsenic in Chinese-language pharmacopeial practice and dominated by arsenite, is the most toxic fraction; arsenic and inorganic arsenic compounds are classified as Group 1 human carcinogens by the International Agency for Research on Cancer (IARC). Consequently, total arsenic screening alone may either overestimate or underestimate actual risk, and species-specific determination is required for accurate safety assessment.

Modern testing therefore combines speciation-preserving extraction with liquid chromatography and element-specific detection. The Chinese Pharmacopoeia (2020 Edition) establishes the methodological basis in General Chapter 2321 for arsenic speciation, and sets a general limit of 2 mg/kg for total arsenic in herbal drugs and decoction pieces unless a monograph specifies otherwise. Internationally, USP General Chapter <232> sets a permitted daily exposure of 15 μg/day for oral drug products, and Codex Alimentarius limits inorganic arsenic in rice products to 0.2 mg/kg, illustrating the global shift toward species-based control.

Testing Samples

Root and Rhizome Materials

Roots and rhizomes are in direct, prolonged contact with soil and typically show the highest arsenic accumulation. Commonly tested materials include ginseng root, Panax notoginseng root, Astragalus membranaceus root, Angelica sinensis root, Salvia miltiorrhiza root, and Coptis chinensis rhizome. These matrices are dense and fibrous, requiring fine grinding to ensure representative and reproducible results.

Aerial Parts: Leaves, Flowers, and Whole Herbs

Materials such as Lonicera japonica flower bud, Chrysanthemum morifolium flower, Ginkgo biloba leaf, and Houttuynia cordata herb can accumulate arsenic from atmospheric deposition and irrigation water. Their high surface-area-to-mass ratio makes thorough washing documentation and homogenization particularly important before analysis.

Fruits, Seeds, and Processed Materials

Lycium barbarum fruit, Citrus reticulata peel, ziziphus seed, honey-fried and carbonized decoction pieces, herbal extracts, and concentrated granules are also routinely tested. Processed materials require attention to concentration factors, since extraction and drying can elevate arsenic levels relative to the raw herb.

Animal-Derived and Mineral-Associated Materials

Animal-derived medicines such as Hirudo (leech) and Pheretima (earthworm), together with compound formulations containing mineral arsenicals such as realgar, demand careful speciation work. In realgar-containing products, the balance between poorly soluble sulfide-bound arsenic and extractable inorganic species directly determines the clinical risk profile.

For all categories, a representative sample of 100 to 500 g is collected, dried below 60 °C to constant weight, ground to pass a 60-mesh (approximately 0.25 mm) sieve, and stored in sealed containers protected from light and moisture until analysis.

Testing Items

  • Arsenite As(III) concentration, the principal low-valence inorganic species and primary toxicological target.
  • Arsenate As(V) concentration, the second major inorganic species.
  • Monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA), the less toxic methylated metabolites.
  • Total inorganic arsenic, calculated as the sum of As(III) and As(V).
  • Total arsenic, determined independently after closed-vessel microwave digestion.
  • Extraction efficiency and mass balance, expressed as the percentage of total arsenic recovered in the speciation extract.

All speciation results are reported in mg/kg on a dry-weight basis, together with the extraction recovery, so that clients can interpret both the absolute toxicity of the inorganic fraction and the completeness of the extraction.

Testing Methods

Speciation-Preserving Extraction

A 0.2 to 0.5 g portion of ground sample is extracted with 10 to 20 mL of ultrapure water, dilute hydrochloric acid (0.01 to 0.1 mol/L), or artificial gastric fluid as specified in the relevant pharmacopeial procedure. Extraction is performed by ultrasound for 30 to 60 minutes with the bath temperature controlled below 40 °C, or by gentle microwave assistance at 60 to 80 °C. The extract is centrifuged, filtered through a 0.22 μm membrane, protected from light, and analyzed within 24 hours. These mild, oxygen-limited conditions minimize interconversion between As(III) and As(V) during preparation.

Chromatographic Separation by HPLC

Species separation is achieved on a strong anion-exchange column such as the Hamilton PRP-X100 (250 mm × 4.1 mm, 10 μm). A 10 to 25 mmol/L ammonium phosphate buffer at pH 5.8 to 6.0 is used as the mobile phase at 1.0 mL/min, with a 10 to 20 μL injection volume and a column temperature of 25 to 30 °C. Under these conditions, neutral arsenite elutes first near the void volume, followed by DMA, MMA, and finally arsenate, with baseline resolution typically achieved within 10 to 15 minutes.

Detection by ICP-MS

Coupling the HPLC outlet to an inductively coupled plasma mass spectrometer provides element-specific detection at mass 75. The polyatomic interference from 40Ar35Cl+ is removed using helium collision mode with kinetic energy discrimination, and germanium (m/z 72 or 74) serves as the internal standard to correct for plasma drift. Method detection limits reach 0.05 μg/L or lower in the injected solution, corresponding to approximately 0.002 to 0.01 mg/kg in the herbal matrix.

Detection by Hydride Generation AFS

For laboratories using atomic fluorescence spectrometry, the column effluent is mixed online with hydrochloric acid (3 to 7%) and potassium borohydride (1.5 to 2% in 0.5% KOH), with potassium persulfate added as a post-column oxidant to convert all species into a hydride-active form. The generated arsine is swept by argon into an electrically heated quartz atomizer and measured with an arsenic hollow cathode lamp. This configuration is cost-effective, sensitive, and widely deployed in Chinese testing laboratories, with detection limits around 0.1 μg/L.

Total Arsenic and Quality Assurance

Total arsenic is determined after microwave digestion with nitric acid and hydrogen peroxide, followed by hydride generation AFS with thiourea–ascorbic acid pre-reduction or by ICP-MS. Analytical quality is demonstrated through multi-point calibration with correlation coefficients of at least 0.999, spike recoveries between 80% and 120%, replicate precision (RSD) below 5% for n = 6, and analysis of certified reference materials such as GBW07605 bush leaves or NIST SRM 1573a tomato leaves. The governing references include Chinese Pharmacopoeia 2020 General Chapters 2321, GB 5009.11 for total arsenic, and the USP <232>/<233> elemental impurities framework for products intended for international markets.

Applications

  • Incoming material inspection and routine release testing for manufacturers of herbal drugs, decoction pieces, extracts, and concentrated granules.
  • Pharmacopeial compliance verification and registration dossiers for domestic marketing authorization and export certification.
  • Risk screening of cultivation sites under Good Agricultural Practice (GAP) programs, guiding site selection and soil remediation decisions.
  • Research into arsenic speciation transformation during washing, soaking, boiling, stir-frying, and other traditional processing steps.
  • Safety assessment of realgar-containing compound formulations, where distinguishing sulfide-bound arsenic from extractable inorganic arsenic is essential.
  • Support for import and export inspections, trade dispute resolution, and post-market surveillance programs.

By pairing species-specific data with total arsenic results, producers can demonstrate that a material not only meets regulatory concentration limits but also presents an acceptable toxicological profile for its intended dose and duration of use.

FAQ

Why is speciation analysis necessary when total arsenic is already regulated?

Regulatory limits are increasingly based on inorganic arsenic because toxicity varies dramatically among species. A herb exceeding a screening threshold for total arsenic may contain mostly low-toxicity organic species, while another herb with acceptable total arsenic could theoretically carry a disproportionate inorganic burden. Speciation analysis resolves this ambiguity and supports scientifically defensible risk decisions.

What is the regulatory limit for arsenic in Chinese herbal medicines?

The Chinese Pharmacopoeia (2020 Edition) sets a general limit of 2 mg/kg for total arsenic in herbal drugs and decoction pieces, with some monographs specifying different values. For products sold into regulated Western markets, USP <232> establishes a permitted daily exposure of 15 μg/day for oral drug products, evaluated against the maximum daily dose of the article.

How much sample is required and how should it be submitted?

A minimum of 100 g of dried, representative material is recommended, sealed in clean polyethylene or glass containers and shipped with protection from moisture and contamination. Homogenization to 60 mesh is performed in the laboratory before weighing.

Can As(III) and As(V) interconvert during the analysis?

Yes, interconversion is the principal technical challenge in arsenic speciation. It is controlled by using mild, dilute extraction media, temperatures below 40 °C, minimal extraction times, amber vials, and same-day instrumental analysis. Method validation includes checks on species stability in the prepared extract.

What detection limits and turnaround time can be expected?

Typical method detection limits are 0.002 to 0.01 mg/kg for individual arsenic species in herbal matrices. Standard projects are completed within 7 to 10 working days after sample receipt, with expedited service available for urgent release testing.